170 related articles for article (PubMed ID: 33303488)
1. Bacille Calmette-Guérin inoculation site changes and cardiac complications in patients with Kawasaki disease.
Takikawa H; Ae R; Matsubara Y; Matsubara D; Makino N; Kosami K; Kuwabara M; Sasahara T; Nakamura Y
Arch Dis Child; 2021 Jul; 106(7):669-673. PubMed ID: 33303488
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan.
Sudo D; Makino N; Nakamura Y
Arch Dis Child; 2020 Sep; 105(9):848-852. PubMed ID: 32107252
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Complications, Earlier Treatment, and Initial Disease Severity in Kawasaki Disease.
Abrams JY; Belay ED; Uehara R; Maddox RA; Schonberger LB; Nakamura Y
J Pediatr; 2017 Sep; 188():64-69. PubMed ID: 28619520
[TBL] [Abstract][Full Text] [Related]
4. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
[TBL] [Abstract][Full Text] [Related]
5. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site.
Uehara R; Igarashi H; Yashiro M; Nakamura Y; Yanagawa H
Pediatr Infect Dis J; 2010 May; 29(5):430-3. PubMed ID: 20032807
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018.
Ae R; Makino N; Kosami K; Kuwabara M; Matsubara Y; Nakamura Y
J Pediatr; 2020 Oct; 225():23-29.e2. PubMed ID: 32454114
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
Takekoshi N; Kitano N; Takeuchi T; Suenaga T; Kakimoto N; Suzuki T; Kada TT; Shibuta S; Tachibana S; Murayama Y; Yamaga H; Suzuki H
JAMA Netw Open; 2022 Jun; 5(6):e2216642. PubMed ID: 35696166
[TBL] [Abstract][Full Text] [Related]
9. Kawasaki disease in children with Bacillus Calmette-Guérin scar reactivity: Focus on coronary outcomes.
Yang MC; Wu KL; Huang CN; Liu YC; Chien YH; Fu CM; Lim HK; Chin CY; Wu JR; Liu HM; Sun LC; Lee CY; Su YH; Wang YF; Lin MT
J Formos Med Assoc; 2023 Oct; 122(10):1001-1007. PubMed ID: 37142476
[TBL] [Abstract][Full Text] [Related]
10. Erythema and induration of the Bacillus Calmette-Guérin site for diagnosing Kawasaki disease.
Loh ACE; Kua PHJ; Tan ZL
Singapore Med J; 2019 Feb; 60(2):89-93. PubMed ID: 30009317
[TBL] [Abstract][Full Text] [Related]
11. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
Yamashita M; Ae R; Yashiro M; Aoyama Y; Sano T; Makino N; Nakamura Y
Pediatr Cardiol; 2017 Feb; 38(2):375-380. PubMed ID: 27878631
[TBL] [Abstract][Full Text] [Related]
12. Time course of cardiac lesions due to Kawasaki disease in Japan: 22nd nationwide survey (2011-2012).
Goto T; Sano T; Kojo T; Ae R; Aoyama Y; Makino N; Kotani K; Nakamura Y
Pediatr Int; 2016 Dec; 58(12):1274-1276. PubMed ID: 27285479
[TBL] [Abstract][Full Text] [Related]
13. The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan.
Kuwabara M; Yashiro M; Ae R; Yanagawa H; Nakamura Y
Int J Cardiol; 2018 Oct; 269():334-338. PubMed ID: 30049499
[TBL] [Abstract][Full Text] [Related]
14. Reaction at the bacillus Calmette--Guérin inoculation site in patients with Kawasaki disease.
Lai CC; Lee PC; Wang CC; Hwang BT; Meng CC; Tsai MC
Pediatr Neonatol; 2013 Feb; 54(1):43-8. PubMed ID: 23445742
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High-Risk Patients With Kawasaki Disease.
Ae R; Abrams JY; Maddox RA; Schonberger LB; Nakamura Y; Kuwabara M; Makino N; Matsubara Y; Kosami K; Sasahara T; Belay ED
J Am Heart Assoc; 2020 Sep; 9(17):e015308. PubMed ID: 32811256
[TBL] [Abstract][Full Text] [Related]
16. Two infants with tuberculid associated with Kawasaki disease.
Yamada H; Ohta H; Hasegawa S; Azuma Y; Hasegawa M; Kadoya R; Ohbuchi N; Ohnishi Y; Okada S; Hoshide M; Ohga S
Hum Vaccin Immunother; 2016 Nov; 12(11):2772-2776. PubMed ID: 27435523
[TBL] [Abstract][Full Text] [Related]
17. Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease.
Novais C; Fortunato F; Bicho A; Preto L
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033285
[TBL] [Abstract][Full Text] [Related]
18. Seasonality of i.v. immunoglobulin responsiveness in Kawasaki disease.
Kido S; Ae R; Kosami K; Matsubara Y; Makino N; Sasahara T; Kuwabara M; Aoyama Y; Yashiro M; Yanagawa H; Nakamura Y
Pediatr Int; 2019 Jun; 61(6):539-543. PubMed ID: 30980447
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
[TBL] [Abstract][Full Text] [Related]
20. BCG and Kawasaki disease in Mexico and Japan.
Gamez-Gonzalez LB; Hamada H; Llamas-Guillen BA; Ruiz-Fernandez M; Yamazaki-Nakashimada M
Hum Vaccin Immunother; 2017 May; 13(5):1091-1093. PubMed ID: 28281896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
